CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that the company’s PurISTSM algorithmic test has received a ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that the company’s PurIST SM algorithmic test has received a ...

Tempus AI (TEM) announced the clinical launch of its Immune Profile Score (IPS) algorithmic test. IPS, which is now available for clinicians to order, is a multimodal biomarker that can be used as a ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that its multimodal immune profile score (IPS) algorithmic test is ...

As design complexity increases, design verification becomes increasingly difficult. In fact, it is not uncommon for project teams to spend more time verifying that a design will work than creating the ...

Forbes contributors publish independent expert analyses and insights. Gus Alexiou is a London-based reporter covering disability inclusion. The use of software algorithms to assist in organizational ...

Kate Smith-Miles receives funding from the Australian Research Council as a Georgina Sweet Australian Laureate Fellow, and as a Chief Investigator in the Australian Centre of Excellence in ...